Neuren Pharmaceuticals Limited (ASX:NEU)
14.54
+0.74 (5.36%)
May 29, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $24.00 | Buy | Maintains | $24.00 | +65.06% | May 19, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $22.00 | Buy | Maintains | $22.00 | +51.31% | May 9, 2026 |
| Macquarie | Macquarie | Buy Maintains $19.10 | Buy | Maintains | $19.10 | +31.36% | Mar 3, 2026 |
| Jefferies | Jefferies | Buy Maintains $27.00 | Buy | Maintains | $27.00 | +85.69% | Feb 6, 2026 |
| Petra Capital | Petra Capital | Buy Maintains $29.96 | Buy | Maintains | $29.96 | +106.05% | Feb 5, 2026 |
Unknown Analyst Ord Minnett No rating | Ord Minnett | Buy Maintains $30.50 | Buy | Maintains | $30.50 | +109.77% | Jan 15, 2026 |